Aurobindo Pharma, part of the pharma space, has rallied more than 100% in FY24 but found some resistance above Rs 1,100 levels in January 2024. The stock underwent price wise correction since January 2024 and is now showing signs of bottoming out which suggests that bulls are ready to take the charge again. Short-term traders … Read more
SRF, part of the specialty chemical space, remained rangebound for the past 1 year but recent momentum helped the stock to break out from a 9-month consolidation on the weekly charts. Short-term traders can look to buy the stock now for a possible target of Rs 2,900-3,000 in the next 3-4 weeks, suggest experts. The … Read more
Brokerage firm Citigroup maintained a neutral rating on RIL, Jefferies retained a buy rating on Marico, Macquarie has a neutral rating on Bajaj Finance while Investec recommended a buy on Gail India and ITC post Q3 results. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Citigroup on … Read more
Indian market is likely to trade higher on Wednesday tracking positive global cues. Nifty future closed positive with gains of 0.45% at 21499 levels on Tuesday. India VIX was up by 7.08% from 13.70 to 14.68 levels. Volatility spiked to higher zones and created some swings in the market. Positive setup was seen in stocks … Read more
